Curative Biotechnology Inc (CUBT)

[Wrangler1]

And Dr. Sohn is the CUBT lead on the CRADA and will be working closely with Dr. Chew, the National Eye Institute’s lead investigator on the trials. She has a vested interest in this trial’s success. And let’s not forget Dr. Sohn started the U.S. Vaccine Business for SmithKline Beecham and led the launch of its first vaccine in the U.S. and helped shape their global vaccine portfolio pipeline as a member of the International Vaccine Steering Committee.

I think she knows a thing or two about developing products and bringing them to market. The bears here will call her “eye candy” though which is pretty laughable. She’s fully engaged and has a lot riding on its success.